북미의 산모 정신 건강 시장 규모, 점유율, 동향 분석 리포트:적응 질환별, 치료법별, 지역별, 부문 동향(2023-2030년)

North America Maternal Mental Health Market Growth & Trends

The North America maternal mental health market size is expected to reach USD 20.63 billion by 2030, growing at a CAGR of 29.68% from 2023 to 2030, according to a new report by Grand View Research, Inc. The maternal mental health industry in the U.S. has been growing in recent years, with increased awareness, improved screening and assessment, and efforts to enhance access to care. However, disparities in access as well as gaps in mental well-being support for vulnerable populations still exist. The Canadian government has implemented regulations and provided funding to address maternal mental conditions.

These include initiatives such as maternity leave benefits under the Employment Insurance program, mental well-being strategies, funding for perinatal mental health services, collaborative care models, research and data collection, and support for community-based organizations. These efforts aim to improve access to mental well-being services and support for pregnant women and new mothers across Canada. Moreover, the Wisconsin Department of Health Services (DHS) announced awards totaling USD 16 million in October 2022 to enhance maternal and child health. The funds will be invested to close maternal and child health outcomes gaps through collaborations with the Medical College of Wisconsin's Advancing a Healthier Wisconsin Endowment and the University of Wisconsin School of Medicine and Public Health.

In addition, this initiative offers funding to DHS Maternal and Child Health Program to manage a grant program. This program will provide funding for initiatives that promote maternal and child health equity to reduce maternal and infant mortality at the systemic and community levels and improve outcomes for families throughout Wisconsin. Each partner will receive USD 5.5 million to help them with their projects. With the help of increased funds, the government can determine the precise causes of each maternal mortality. The government will then be able to extend and implement evidence-based programs in hospitals and other birthing facilities to deal with the fundamental problems that result in poor maternal condition outcomes.

Although postnatal depression affects 15% of new mothers, it is frequently masked by stigma, societal expectations, and lack of medical knowledge. Despite the stigmatizing nature of mental illness, women have shown ingenuity and resilience by using acceptable cultural movements to reframe their experiences of PPD, challenging conventional views of motherhood, and successfully gaining recognition of their sufferings. The social stigma associated with PPD is a serious problem in the U.S. Many people think PPD is an unreal ailment or a sign of weakness. Therefore, some women might hesitate to seek treatment for PPD out of concern that they would be stigmatized or condemned.

North America Maternal Mental Health Market Report Highlights

• The pregnancy and postpartum general anxiety segment accounted for the largest share in 2022. Increasing awareness and recognition of perinatal mental condition issues including anxiety disorders is the major factor driving the segment growth
• The PPD segment is expected to witness a lucrative CAGR through 2023 - 2030 owing to the favorable reimbursement scenario, increasing awareness for screening, and approval of novel therapies
• IPT dominated the market in 2022 as IPT is considered an effective therapy for treating a variety of mental conditions
• The U.S. led the regional market due to factors contributing such as robust government funding, increasing research, and the presence of prominent players

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation
  • 1.1.1. Market Definitions
• 1.2. Objectives
  • 1.2.1. Objective - 1
  • 1.2.2. Objective - 2
  • 1.2.3. Objective - 3
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. Gvr's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
• 1.5. Information or Data Analysis
  • 1.5.1. Data Analysis Models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity Flow Analysis
• 1.8. List of Secondary Sources
• 1.9. List of Abbreviations
• 1.10. List of Primary Sources

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Disease Indication and Therapy Snapshot 1
• 2.3. Competitive Landscape Snapshot

Chapter 3. North America Maternal Mental Health Market Variables and Trends

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Impact Analysis
    • 3.2.1.1. Rise in government funding to reduce the maternal mortality
    • 3.2.1.2. Increasing incidence of post-partum depression
    • 3.2.1.3. Rise in awareness programs and efforts to improve practices around maternal mental healthcare
  • 3.2.2. Market Restraint Impact Analysis
    • 3.2.2.1. Mental health workforce shortage
    • 3.2.2.2. Social stigma surrounding postpartum depression
• 3.3. Impact of the COVID-19 Pandemic
• 3.4. Industry Analysis Tools
  • 3.4.1. Porter's Analysis
  • 3.4.2. Swot Analysis; By Factor (Political & Legal, Economic And Technological)

Chapter 4. North America Maternal Mental Health Market: Disease Indication Estimates & Trend Analysis

• 4.1. Disease Indication Movement Analysis & Market Share, 2022 & 2030
• 4.2. North America Maternal Mental Health Market Estimates & Forecast, By Disease Indication (USD Million)
• 4.3. Postpartum Depression
  • 4.3.1. Global Postpartum Depression Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 4.4. Dysthymia
  • 4.4.1. Global Dysthymia Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 4.5. Pregnancy and Postpartum General Anxiety
  • 4.5.1. Global Pregnancy And Postpartum General Anxiety Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 4.6. Pregnancy and Postpartum OCD
  • 4.6.1. Global Pregnancy And Postpartum OCD Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 4.7. Birth-Related PTSD
  • 4.7.1. Global Birth-Related PTSD Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 4.8. Others
  • 4.8.1. Global Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 5. North America Maternal Mental Health Market: Therapy Estimates & Trend Analysis

• 5.1. Therapy Movement Analysis & Market Share, 2022 & 2030
• 5.2. North America Maternal Mental Health Market Estimates & Forecast, By Therapy (USD Million)
• 5.3. Antidepressants
  • 5.3.1. Global Antidepressants Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.3.2. Selective Serotonin Reuptake Inhibitors (SSRIs)
    • 5.3.2.1. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.3.3. Tricyclic Antidepressants (TCAs)
    • 5.3.3.1. Global Tricyclic Antidepressants (TCAs) Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.3.4. Others
    • 5.3.4.1. Global Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 5.4. Interpersonal Psychotherapy (IPT)
  • 5.4.1. Global Interpersonal Psychotherapy (IPT) Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 5.5. Cognitive Behavioral Therapy (CBT)
  • 5.5.1. Global Cognitive Behavioral Therapy (CBT) Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 5.6. Others
  • 5.6.1. Global Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 6. North America Maternal Mental Health Market: Regional Estimates and Trend Analysis

• 6.1. North America Maternal Mental Health Market: Regional Outlook
• 6.2. North America
  • 6.2.1. North America Maternal Mental Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.2.2. U.S.
    • 6.2.2.1. Key Country Dynamics
    • 6.2.2.2. Competitive Scenario
    • 6.2.2.3. Regulatory Framework
    • 6.2.2.4. U.S. North America Maternal Mental Health Market Estimates and Forecasts, 2018 - 2030 (USD MILLION)
  • 6.2.3. Canada
    • 6.2.3.1. Key Country Dynamics
    • 6.2.3.2. Competitive Scenario
    • 6.2.3.3. Regulatory Framework
    • 6.2.3.4. Canada North America Maternal Mental Health Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. North America Maternal Mental Health Market: Competitive Landscape

• 7.1. Participant Categorization
  • 7.1.1. Therapy Mama
    • 7.1.1.1. Overview
    • 7.1.1.2. Product Benchmarking
    • 7.1.1.3. Strategic Initiatives
  • 7.1.2. Canopie
    • 7.1.2.1. Overview
    • 7.1.2.2. Product Benchmarking
    • 7.1.2.3. Strategic Initiatives
  • 7.1.3. Pfizer Inc
    • 7.1.3.1. Overview
    • 7.1.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 7.1.3.3. Product Benchmarking
    • 7.1.3.4. Strategic Initiatives
  • 7.1.4. Viatris Inc.
    • 7.1.4.1. Overview
    • 7.1.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 7.1.4.3. Product Benchmarking
    • 7.1.4.4. Strategic Initiatives
  • 7.1.5. GlaxoSmithKline Inc.
    • 7.1.5.1. Overview
    • 7.1.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 7.1.5.3. Product Benchmarking
    • 7.1.5.4. Strategic Initiatives
  • 7.1.6. Alembic Pharmaceuticals Limited
    • 7.1.6.1. Overview
    • 7.1.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 7.1.6.3. Product Benchmarking
    • 7.1.6.4. Strategic Initiatives
  • 7.1.7. Mallinckrodt Inc.
    • 7.1.7.1. Overview
    • 7.1.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 7.1.7.3. Product Benchmarking
    • 7.1.7.4. Strategic Initiatives
  • 7.1.8. Sage Therapeutics, Inc.
    • 7.1.8.1. Overview
    • 7.1.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 7.1.8.3. Product Benchmarking
    • 7.1.8.4. Strategic Initiatives
  • 7.1.9. Bausch Health Companies Inc.
    • 7.1.9.1. Overview
    • 7.1.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 7.1.9.3. Product Benchmarking
    • 7.1.9.4. Strategic Initiatives
  • 7.1.10. Magellan Health, Inc.
    • 7.1.10.1. Overview
    • 7.1.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 7.1.10.3. Product Benchmarking
    • 7.1.10.4. Strategic Initiatives
• 7.2. Participant's Overview
• 7.3. Financial Performance
• 7.4. Product Benchmarking
• 7.5. Company Market Share Analysis, 2022
• 7.6. Strategy Mapping
  • 7.6.1. Expansion
  • 7.6.2. Acquisition
  • 7.6.3. Product/Service Launch
  • 7.6.4. Others

Chapter 8. Analyst View